China & Siemens — Siemens Healthineers

China: China is a key country in the MSCI Asia Pacific Index region, which is witnessing rapid market growth due to increasing healthcare investments and expanding laboratory infrastructure. Fapon Biotech is targeting the Chinese market with its new technology.

Siemens — Siemens Healthineers: As a key company in the CLIA market, Siemens — Siemens Healthineers is contributing significantly to market advancements with diverse product offerings and strategies.

China: China highlighted regenerative agriculture partnerships and autonomous logistics solutions.

Siemens — Siemens Healthineers: Siemens — Siemens Healthineers demonstrated its full 'China-for-China' R&D and manufacturing capabilities in high-end medical equipment.

China: Home to Mindray; fast-growing market.

Siemens — Siemens Healthineers: Major competitor; benefits from rising demand for advanced analyzers.

China: China co-hosted the 2026 BRICS New Industrial Revolution Partnership Forum and Exhibition, demonstrating its leadership in promoting industrial innovation and digital transformation within the BRICS alliance. China's hospitals have also validated MAXHUB's healthcare solutions.

Siemens — Siemens Healthineers: Siemens — Siemens Healthineers imaging equipment is compatible with MAXHUB's Virtual Cockpit, showing its role in integrated healthcare solutions.

Siemens — Siemens Healthineers: Siemens — Siemens Healthineers is identified as a top company in the radiotherapy market, indicating its strong position to benefit from the projected market growth.